Lbp Am Sa Has $4.59 Million Stake in The Cooper Companies, Inc. (NASDAQ:COO)

LBP AM SA increased its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 6.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 49,913 shares of the medical device company's stock after buying an additional 3,116 shares during the period. LBP AM SA's holdings in Cooper Companies were worth $4,589,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in COO. Covestor Ltd increased its stake in Cooper Companies by 144.9% in the third quarter. Covestor Ltd now owns 338 shares of the medical device company's stock valued at $37,000 after acquiring an additional 200 shares during the last quarter. Ashton Thomas Securities LLC bought a new position in Cooper Companies in the third quarter valued at approximately $25,000. GSA Capital Partners LLP increased its stake in Cooper Companies by 150.6% in the third quarter. GSA Capital Partners LLP now owns 6,993 shares of the medical device company's stock valued at $772,000 after acquiring an additional 4,202 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. increased its stake in Cooper Companies by 1.5% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 443,863 shares of the medical device company's stock valued at $48,976,000 after acquiring an additional 6,489 shares during the last quarter. Finally, KBC Group NV increased its stake in Cooper Companies by 5.1% in the third quarter. KBC Group NV now owns 258,460 shares of the medical device company's stock valued at $28,519,000 after acquiring an additional 12,435 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. Wells Fargo & Company lifted their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the company an "overweight" rating in a research note on Friday, December 6th. Citigroup decreased their price objective on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research note on Friday, March 7th. Piper Sandler reaffirmed an "overweight" rating and set a $115.00 target price (down previously from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Morgan Stanley decreased their target price on shares of Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating on the stock in a research note on Friday, December 6th. Finally, JPMorgan Chase & Co. decreased their target price on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a research note on Friday, March 7th. Four investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $111.89.

Cooper Companies Trading Up 0.1 %

Shares of Cooper Companies stock traded up $0.08 during trading on Wednesday, hitting $80.12. The company's stock had a trading volume of 2,779,841 shares, compared to its average volume of 1,271,113. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The Cooper Companies, Inc. has a 52 week low of $77.05 and a 52 week high of $112.38. The stock has a market cap of $16.02 billion, a price-to-earnings ratio of 41.09, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The stock has a 50-day moving average price of $90.68 and a two-hundred day moving average price of $98.56.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $964.70 million for the quarter, compared to analysts' expectations of $981.25 million. Equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.